Monopar Therapeutics (MNPR) Prepaid Assets (2016 - 2026)
Monopar Therapeutics (MNPR) posted Prepaid Assets of $63745.0 for Q4 2025, down 84.63% sequentially from $414825.0 in Q3 2025, and down 19.18% YoY from $78869.0 in Q4 2024.
Monopar Therapeutics (MNPR) Prepaid Assets (2016 - 2026) Analysis & Trends
Monopar Therapeutics has reported Prepaid Assets for 10 years, with the latest figure at $63745.0 in Q4 2025.
- Quarterly Prepaid Assets fell 19.18% year-over-year to $63745.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $63745.0 (down 19.18% YoY) and the FY2025 annual result came in at $63745.0, down 19.18% from the prior year.
- Prepaid Assets fell to $63745.0 in Q4 2025 per MNPR's latest filing, from $414825.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $523556.0 in Q1 2025 and troughed at $45982.0 in Q4 2022.
- A 5-year average of $159167.5 and a median of $106809.5 in 2021 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2025: Prepaid Assets slumped 78.88% in 2022, then surged 736.85% in 2025.
- Over 5 years, Prepaid Assets stood at $217745.0 in 2021, then plunged by 78.88% to $45982.0 in 2022, then jumped by 44.48% to $66433.0 in 2023, then climbed by 18.72% to $78869.0 in 2024, then fell by 19.18% to $63745.0 in 2025.
- According to Business Quant data, Prepaid Assets over the past three periods registered $63745.0, $414825.0, and $497294.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Monopar Therapeutics | 965.64 Mn | 912.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 464,727.00 |
| Dec 31, 2025 | 63,745.00 |
| Sep 30, 2025 | 414,825.00 |
| Jun 30, 2025 | 497,294.00 |
| Mar 31, 2025 | 523,556.00 |
| Dec 31, 2024 | 78,869.00 |
| Sep 30, 2024 | 49,570.00 |
| Jun 30, 2024 | 61,017.00 |
| Mar 31, 2024 | 118,987.00 |
| Dec 31, 2023 | 66,433.00 |
| Sep 30, 2023 | 73,193.00 |
| Jun 30, 2023 | 109,868.00 |
| Mar 31, 2023 | 106,819.00 |
| Dec 31, 2022 | 45,982.00 |
| Sep 30, 2022 | 55,700.00 |
| Jun 30, 2022 | 189,179.00 |
| Mar 31, 2022 | 193,635.00 |
| Dec 31, 2021 | 217,745.00 |
| Sep 30, 2021 | 106,800.00 |
| Jun 30, 2021 | 95,564.00 |